Research Article | Volume: 6, Issue: 4, April, 2016

Simultaneous estimation of Esomeprazole and Tadalafil in pharmaceutical formulations using High Performance Liquid Chromatography

Mohammed Hamad Ahmed Al-Sharqawi Wael Abu Dayyih Eyad Mallah Tawfiq Arafat   

Open Access   

Published:  Apr 30, 2016

DOI: 10.7324/JAPS.2016.60407

An easily, specific, precise, and accurate reversed-phase HPLC method was developed and validated for simultaneous estimation of esomeprazole ( Nexium®) and tadalafil (Cialis®) in pharmaceutical formulation. The separation was achieved by using Hypersil BDS C18 column (250 mm × 4.6 mm; 5.0 μm) and acetonitrile: 0.05 M potassium dihydrogen phosphate buffer at pH 6 adjusted with phosphoric acid as a mobile phase at a flow rate of 1 mL/min. Detection was carried out at wavelength 285nm. The retention time of esomeprazole and tadalafil were 3.1, 3.7 min, respectively. The linearity was established over the concentration ranges of 60-180μg/mL and 40-120μg/mL with correlation coefficients 0.9998 and 0.9996 for esomeprazole and tadalafil, respectively. The mean recoveries were found to be in the ranges of 98–102% for esomeprazole and tadalafil. The proposed method has been validated as per ICH guidelines and successfully applied to the simultaneous estimation of esomeprazole and tadalafil in pharmaceutical formulation.

Keyword:     Esomeprazole HPLC Tadalafil Validation pharmaceutical formulation.


Hamad M, Al-Sharqawi A, Dayyih WA, Mallah E, Arafat T. Simultaneous estimation of Esomeprazole and Tadalafil in pharmaceutical formulationsusing High Performance Liquid Chromatography. J App Pharm Sci, 2016; 6 (04): 052-059.

Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Article Metrics
371 Views 19 Downloads 390 Total



Related Search

By author names